Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative nosocomial pathogens commonly carry one carbapenemase gene conferring resistance to carbapenems and other beta-lactam antibiotics. However, increasing reports show that double-carbapenemase-producing (DCP) and even multi-carbapenemase-producing (MCP) bacteria are emerging in some parts of the world, diminishing further, in some cases, the already limited treatment options. In the present review, the up-to-date reports of DCP and MCP isolates are summarized and concerns regarding their emergence are discussed.

[1]  V. Miriagou,et al.  Outbreak of Acinetobacter baumannii with Chromosomally Encoded VIM-1 Undetectable by Imipenem-EDTA Synergy Tests , 2008, Antimicrobial Agents and Chemotherapy.

[2]  N. Høiby,et al.  OXA-type carbapenemases. , 2006, The Journal of antimicrobial chemotherapy.

[3]  P. Nordmann,et al.  Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  V. Miriagou,et al.  The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2. , 2010, International journal of antimicrobial agents.

[5]  J. Quinn,et al.  Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia , 2012, Antimicrobial Agents and Chemotherapy.

[6]  G. Rossolini,et al.  FIM-1, a New Acquired Metallo-β-Lactamase from a Pseudomonas aeruginosa Clinical Isolate from Italy , 2012, Antimicrobial Agents and Chemotherapy.

[7]  V. Miriagou,et al.  Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases. , 2010, International journal of antimicrobial agents.

[8]  Y. Yu,et al.  First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital , 2014, Epidemiology and Infection.

[9]  Y. Ni,et al.  First Report of Klebsiella oxytoca Strain Coproducing KPC-2 and IMP-8 Carbapenemases , 2011, Antimicrobial Agents and Chemotherapy.

[10]  R. Bonomo,et al.  Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009). , 2011, The Journal of antimicrobial chemotherapy.

[11]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[12]  R. Albano,et al.  Coproduction of NDM-1 and KPC-2 in Enterobacter hormaechei from Brazil. , 2015, Microbial drug resistance.

[13]  Y. Doi,et al.  Co-Production of NDM-1 and OXA-232 by Klebsiella pneumoniae , 2014, Emerging infectious diseases.

[14]  G. Arlet,et al.  First case of multidrug-resistant blaNDM-1- and blaOXA-232-carrying Klebsiella pneumoniae and its probable cross-transmission in a French hospital. , 2014, International journal of antimicrobial agents.

[15]  N. Grover,et al.  First Report of an Enterobacter ludwigii Isolate Coharboring NDM-1 and OXA-48 Carbapenemases , 2013, Antimicrobial Agents and Chemotherapy.

[16]  A. Vatopoulos,et al.  Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals. , 2012, International journal of antimicrobial agents.

[17]  J. Buer,et al.  Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  Chang Ki Kim,et al.  Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases. , 2010, International journal of antimicrobial agents.

[19]  A. Gales,et al.  Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[20]  M. Exindari,et al.  Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[21]  J. Campos,et al.  Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  N. Grover,et al.  Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a Tertiary Care Centre at Central India. , 2014, Journal of clinical and diagnostic research : JCDR.

[23]  J. Quinn,et al.  First Report of a Pseudomonas aeruginosa Isolate Coharboring KPC and VIM Carbapenemases , 2012, Antimicrobial Agents and Chemotherapy.

[24]  A. Maniatis,et al.  VIM-1 Metallo-β-lactamase in Acinetobacter baumannii , 2006, Emerging infectious diseases.

[25]  Ziyong Sun,et al.  First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes. , 2015, Microbial drug resistance.

[26]  R. Jureen,et al.  Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  P. Nordmann,et al.  Extremely Drug-Resistant Citrobacter freundii Isolate Producing NDM-1 and Other Carbapenemases Identified in a Patient Returning from India , 2010, Antimicrobial Agents and Chemotherapy.

[28]  G. Amicosante,et al.  Carbapenem-resistant Klebsiella pneumoniae harbouring blaKPC-3 and blaVIM-2 from central Italy. , 2013, Diagnostic microbiology and infectious disease.

[29]  K. Kumarasamy,et al.  Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India. , 2012, The Journal of antimicrobial chemotherapy.

[30]  P. Nordmann,et al.  Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  S. Pournaras,et al.  Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. , 2010, The Journal of antimicrobial chemotherapy.

[32]  E. Protonotariou,et al.  Emergence of Klebsiella pneumoniae carrying bla(VIM) and bla(KPC) genes. , 2010, Hippokratia.

[33]  A. Tsakris,et al.  Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  Qing Yang,et al.  Clinical Carbapenem-Resistant Acinetobacter baylyi Strain Coharboring blaSIM-1 and blaOXA-23 from China , 2011, Antimicrobial Agents and Chemotherapy.

[35]  P. Nordmann,et al.  OXA-48-like carbapenemases: the phantom menace. , 2012, The Journal of antimicrobial chemotherapy.

[36]  S. Miyakis,et al.  The challenges of antimicrobial drug resistance in Greece. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  A. Tsakris,et al.  Imported Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Clones in a Greek Hospital: Impact of Infection Control Measures for Restraining Their Dissemination , 2012, Journal of Clinical Microbiology.

[38]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[39]  M. Toleman,et al.  Co-existence of blaNDM-1 and blaKPC-2 in clinical isolates of Klebsiella pneumoniae from Pakistan , 2016, Journal of chemotherapy.

[40]  Fernando García,et al.  Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica. , 2015, Journal of medical microbiology.

[41]  H. Furrer,et al.  Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland. , 2014, International journal of antimicrobial agents.

[42]  G. Daikos,et al.  Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.

[43]  V. Miriagou,et al.  Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases , 2009, Antimicrobial Agents and Chemotherapy.

[44]  F. Tryposkiadis,et al.  Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[45]  A. Oliver,et al.  Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital. , 2012, Microbial drug resistance.

[46]  M. Toleman,et al.  Genetic and Biochemical Characterization of an Acquired Subgroup B3 Metallo-β-Lactamase Gene, blaAIM-1, and Its Unique Genetic Context in Pseudomonas aeruginosa from Australia , 2012, Antimicrobial Agents and Chemotherapy.

[47]  L. Li,et al.  Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both blaKPC-2 and blaIMP-4 , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[48]  A. Maniatis,et al.  Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. , 2006, The Journal of antimicrobial chemotherapy.

[49]  Michalis Polemis,et al.  An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). , 2011, The Journal of antimicrobial chemotherapy.

[50]  E. Aquino,et al.  First report of a Pseudomonas aeruginosa clinical isolate co-harbouring KPC-2 and IMP-18 carbapenemases. , 2012, International journal of antimicrobial agents.

[51]  U. Sekar,et al.  bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. , 2012, Journal of infection in developing countries.

[52]  I. Goic-Barisic,et al.  Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. , 2011, The Journal of hospital infection.

[53]  F. Rossi,et al.  Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance , 2014, Annals of Clinical Microbiology and Antimicrobials.

[54]  A. Baronia,et al.  Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-beta-lactamase genes. , 2009, Indian journal of pathology & microbiology.

[55]  E. Petinaki,et al.  Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[56]  Yen-Hsu Chen,et al.  Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. , 2008, International journal of antimicrobial agents.